Results 261 to 270 of about 4,224,198 (351)
Aims The Medicines and Healthcare products Regulatory Agency (MHRA) introduced a risk‐proportionate approach to assess clinical trial applications for authorisation in August 2023. This study evaluates the impact of this approach on the timelines for reviewing proposals.
Andrea Manfrin +6 more
wiley +1 more source
Aims To assess the utility of the artificial intelligence (AI) chatbot ChatGPT (openly available version 3.5) in responding to real‐world pharmacotherapeutic queries from healthcare professionals. Methods Three independent and blinded evaluators with different levels of medical expertise and professional experience (beginner, advanced, and expert ...
Benjamin Krichevsky +9 more
wiley +1 more source
Psychiatrists' opinions about non-medicalization of cannabis use disorder in Iran. [PDF]
Namazi H, Sayyah M.
europepmc +1 more source
Artificial intelligence guidance in ethically challenging clinical scenarios in child and adolescent psychiatry: a qualitative study in the context of Turkiye. [PDF]
İçen S, Köken AH.
europepmc +1 more source
Challenges and dynamics in reporting medical device incidents: a qualitative study. [PDF]
Mishali M, Sheffer N, Negev M.
europepmc +1 more source
Applications of Medical Mediation: A Systematic Review of Its Role in Healthcare Dispute Resolution and Bioethical Decision-Making. [PDF]
Lioupi O +4 more
europepmc +1 more source

